Gene Data From HGNC: https://www.genenames.org/download/statistics-and-files/
Symbol:
ERCC1
Name:
ERCC excision repair 1 endonuclease non-catalytic subunit
Location:
19q13.32
Locus Group:
protein-coding gene
Gene Type:
Protein Coding
Locus Type:
gene with protein product
Clinical Trials Data: https://classic.clinicaltrials.gov/api/gui/ref/download_all
Clinical Studies
| NCT Number | Status | Brief Title | View |
|---|---|---|---|
| NCT01444547 | A Study on Predictive Value of ERCC1 in Esophageal Cancer Patients Treated With Paclitaxel and Cisplatin | View | |
| NCT00953511 | Cologne Esophageal Response Prediction Study CERP-Study | View | |
| NCT01556191 | Lung Cancer in Women Treated With Anti-oestrogens anD Inhibitors of EGFR | View | |
| NCT01240590 | A Phase III Trial of Crolibulin EPC2407 Plus Cisplatin in Adults With Solid Tumors With a Focus on Anaplastic Thyroid Cancer ATC | View | |
| NCT01989546 | Pilot Trial of BMN 673 an Oral PARP Inhibitor in Patients With Advanced Solid Tumors and Deleterious BRCA Mutations | View | |
| NCT01074398 | Biomarkers in Predicting Response in Patients With Advanced Ovarian Epithelial Cancer Fallopian Tube Cancer or Primary Peritoneal Cancer Treated on GOG-0172 or GOG-0182 | View | |
| NCT00174629 | GILT Docetaxel - Non-Small Cell Lung Cancer | View | |
| NCT02838745 | Study of Cytoreductive Surgery and Hyperthermic Intraoperative Chemotherapy With Pemetrexed and Cisplatin for MPM | View | |
| NCT04466189 | Prospective Cohort Study of Pancreatic Cancer Patients Treated With Proton Beam Therapy | View | |
| NCT00582634 | Adjuvant Cisplatin and Docetaxel in Non Small Cell Lung Cancer | View | |
| NCT00736814 | First-Line Combination Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery | View | |
| NCT00792701 | S0720 Adjuvant Therapy Based on Gene Expression in Stage IA and IB Non-Small Cell Lung Cancer | View | |
| NCT02128906 | Radiotherapy With Cisplatin vs Docetaxel-cetuximab in HNSCC ERCC1 Biomarker Enrichment and Interaction Design | View | |
| NCT01188109 | GemcitabineCisplatin for Resected Pancreas Cancer Establishing the Role of ERCC1 in Treatment Decision | View | |
| NCT01280643 | Combination Chemotherapy and Cetuximab or Bevacizumab in Treating Patients With Metastatic Colorectal Cancer | View | |
| NCT01781988 | Personalized Therapy in Non-small Cell Lung Cancer | View | |
| NCT01784549 | Customized Neoadjuvant Versus Standard Chemotherapy in NSCL Patients With Resectable Stage IIIA N2Disease | View | |
| NCT01524575 | Gemcitabine and Oxaliplatin in the Management of Metastatic Pancreatic Cancers With Low Expression of ERCC1 | View | |
| NCT01648517 | Genotype-Driven Treatment of Advanced Non-small Cell Lung Cancer Based on mRNA Expression of ERCC1 RRM1 as First-line Chemotherapy | View | |
| NCT01703390 | Biomarker Directed Treatment in Metastatic Colorectal Cancer | View | |
| NCT01967875 | A Phase 2 Trial of Optimizing Platinum-Based Chemotherapy Based on ERCC1 Expression as First-Line Treatment in Patients With Locally Advanced or Metastatic Gastric Cancer | View | |
| NCT03402048 | The EPIC Trial The Elderly Patient Individualized Chemotherapy Trial | View | |
| NCT00006155 | SU5416 and Carboplatin to Treat Ovarian Cancer | View | |
| NCT05247671 | Evaluation of the Effect of Genetic Polymorphisms in ERCC1 and OCT2 on the Occurrence and Severity of Cisplatin-induced Nephrotoxicity | View | |
| NCT05832593 | Immunohistochemical Expression of Excision Repair Cross Complementation Group 1 ERCC1 in Laryngeal Squamous Cell Carcinoma and Its Correlation With Response to Radiotherapy | View | |
| NCT01071655 | Selecting Treatment in Colorectal CancerCapecitabine or 5-fluorouracil Selection to be Combined With Oxaliplatin or Irinotecan as First-line Chemotherapy in Advanced Colorectal Cancer | View | |
| NCT01141686 | Non Small Cell Lung Cancer Evaluation According to Pre-determined Drug-targeting Tumor Markers | View | |
| NCT00705549 | Individualized Therapy Based of Tumoral mRNA Levels of ERCC1 RRM1 and BRCA1 in Advanced Non-Small-Cell Lung Cancer | View | |
| NCT01192750 | Biomakers in Tissue Samples From Patients With Recurrent andor Metastatic Squamous Cell Cancer of the Head and Neck Previously Treated With Cisplatin With or Without Cetuximab | View | |
| NCT00499109 | Phase III of RRM1 ERCC1 Directed Customized Chemotherapy for the Treatment of Patients With NSCLC | View | |
| NCT00634647 | Satraplatin and Prednisone to Treat Prostate Cancer | View | |
| NCT00775385 | TAilored Post-Surgical Therapy in Early Stage NSCLC | View | |
| NCT00797238 | DNA Repair Genes and Outcomes in Patients With Stage III NSCLC | View | |
| NCT00801736 | ERCC1 Targeted Trial | View |